choline and Adenoma
choline has been researched along with Adenoma in 35 studies
Adenoma: A benign epithelial tumor with a glandular organization.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "F-fluorocholine PET/CT detected 52 of 54 patients and 52 of 56 lesions with histopathologically proven parathyroid adenomas on patient-based and lesion-based analysis, respectively." | 9.24 | Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism. ( Behera, A; Bhadada, SK; Dahiya, D; Gorla, AKR; Kalathoorakathu, RR; Mittal, BR; Rao, SD; Saikia, UN; Singh, P; Sood, A; Thanseer, N, 2017) |
| "This prospective pilot study was aimed to evaluate ¹¹C-choline PET/CT (choline) as a tool for localization of parathyroid adenoma (PTA)." | 9.19 | Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results. ( Bocher, M; Freedman, N; Jacobson, O; Krausz, Y; Mishani, E; Orevi, M, 2014) |
| "PubMed/Medline and Embase databases were searched up to October 2020 for studies estimating the diagnostic accuracy of 11C-Methionine PET or 18F-Fluorocholine PET for parathyroid localization in patients with primary hyperparathyroidism." | 9.12 | Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. ( Barale, M; Berton, AM; Bioletto, F; Deandreis, D; Ghigo, E; Parasiliti-Caprino, M; Prencipe, N; Procopio, M, 2021) |
| "Patients with primary hyperparathyroidism were recruited from February 2016 to August 2017 and F18-fluorocholine positron emission tomography/magnetic resonance imaging was performed to localize the parathyroid adenoma prior to surgery." | 7.91 | The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas. ( Azoulay, O; Bernstine, H; Domachevsky, L; Groshar, D; Khafif, A; Landsberg, R; Lockman, Y; Masalha, M, 2019) |
| "To evaluate the sensitivity of F18-choline (FCH) PET/CT for parathyroid adenoma detection prior to surgery in patients with primary hyperparathyroidism and negative or inconclusive cervical ultrasound and Tc99m-sestaMIBI SPECT/CT." | 7.88 | F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study. ( Aide, N; Bardet, S; Blanchard, D; Ciappuccini, R; Clarisse, B; de Raucourt, D; Grellard, JM; Houdu, B; Le Roux, Y; Licaj, I; Lireux, B; Quak, E; Reznik, Y, 2018) |
| "We report the incidental finding of a pituitary macroadenoma on an F-choline PET/CT in a patient with recurrent prostate cancer." | 7.83 | Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse. ( Colletti, PM; Maffione, AM; Mandoliti, G; Pasini, F; Rubello, D, 2016) |
| "18F-fluorocholine PET-CT is a new imaging modality for the localization of pathological parathyroid glands in patients with primary hyperparathyroidism." | 7.81 | [18F-Fluorocholine PET-CT for localization of parathyroid adenomas]. ( Borel Rinkes, IH; de Keizer, B; de Klerk, JM; Kluijfhout, WP; Valk, GD; Vriens, MR, 2015) |
| "Choline and betaine are involved in methyl-group metabolism as methyl-group donors; thus, like folate, another methyl-group donor, they may be associated with a reduced risk of colorectal adenomas." | 7.74 | Dietary choline and betaine and the risk of distal colorectal adenoma in women. ( Chan, AT; Cho, E; Colditz, GA; Fuchs, CS; Giovannucci, EL; Willett, WC; Wu, K; Zeisel, SH, 2007) |
| "However, no parathyroid adenoma was depictable." | 5.72 | Synchronous Metastatic Medullary Thyroid Carcinoma and Paraesophageal Parathyroid Adenoma Detected on 18 F-Ethylcholine PET/US Fusion Imaging. ( Freesmeyer, M; Männel, M; Mtuka-Pardon, G; Müller, UA; Seifert, P, 2022) |
| "F-Fluorocholine PET/CT was quickly performed considering this discrepancy and not only confirmed the scintigraphic findings but also revealed a second contralateral focus of increased uptake, both later confirmed by operative consideration (the two other parathyroid glands are considered normal by the surgeon), pathology, and intraoperative parathyroid hormone assessment." | 5.46 | Incremental Value of 18F-Fluorocholine PET/CT in the Localization of Double Parathyroid Adenomas. ( Deguelte, S; Lalire, P; Ly, S; Morland, D; Patey, M, 2017) |
| "Prostate carcinoma is the most common cancer in men." | 5.46 | Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017) |
| "The finding was suggestive for a parathyroid adenoma on subsequent ultrasound, then finally confirmed by parathyroid scintigraphy and histopathological analysis performed after hemithyroidectomy." | 5.38 | Incidental finding of parathyroid adenoma with 11C-choline PET/CT. ( Busnardo, E; Freschi, M; Gianolli, L; Magnani, P; Mapelli, P; Messa, C; Picchio, M, 2012) |
| "F-fluorocholine PET/CT detected 52 of 54 patients and 52 of 56 lesions with histopathologically proven parathyroid adenomas on patient-based and lesion-based analysis, respectively." | 5.24 | Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism. ( Behera, A; Bhadada, SK; Dahiya, D; Gorla, AKR; Kalathoorakathu, RR; Mittal, BR; Rao, SD; Saikia, UN; Singh, P; Sood, A; Thanseer, N, 2017) |
| "This prospective pilot study was aimed to evaluate ¹¹C-choline PET/CT (choline) as a tool for localization of parathyroid adenoma (PTA)." | 5.19 | Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results. ( Bocher, M; Freedman, N; Jacobson, O; Krausz, Y; Mishani, E; Orevi, M, 2014) |
| "PubMed/Medline and Embase databases were searched up to October 2020 for studies estimating the diagnostic accuracy of 11C-Methionine PET or 18F-Fluorocholine PET for parathyroid localization in patients with primary hyperparathyroidism." | 5.12 | Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. ( Barale, M; Berton, AM; Bioletto, F; Deandreis, D; Ghigo, E; Parasiliti-Caprino, M; Prencipe, N; Procopio, M, 2021) |
| "Patients with primary hyperparathyroidism were recruited from February 2016 to August 2017 and F18-fluorocholine positron emission tomography/magnetic resonance imaging was performed to localize the parathyroid adenoma prior to surgery." | 3.91 | The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas. ( Azoulay, O; Bernstine, H; Domachevsky, L; Groshar, D; Khafif, A; Landsberg, R; Lockman, Y; Masalha, M, 2019) |
| "To evaluate the sensitivity of F18-choline (FCH) PET/CT for parathyroid adenoma detection prior to surgery in patients with primary hyperparathyroidism and negative or inconclusive cervical ultrasound and Tc99m-sestaMIBI SPECT/CT." | 3.88 | F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study. ( Aide, N; Bardet, S; Blanchard, D; Ciappuccini, R; Clarisse, B; de Raucourt, D; Grellard, JM; Houdu, B; Le Roux, Y; Licaj, I; Lireux, B; Quak, E; Reznik, Y, 2018) |
| "We report the incidental finding of a pituitary macroadenoma on an F-choline PET/CT in a patient with recurrent prostate cancer." | 3.83 | Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse. ( Colletti, PM; Maffione, AM; Mandoliti, G; Pasini, F; Rubello, D, 2016) |
| "18F-fluorocholine PET-CT is a new imaging modality for the localization of pathological parathyroid glands in patients with primary hyperparathyroidism." | 3.81 | [18F-Fluorocholine PET-CT for localization of parathyroid adenomas]. ( Borel Rinkes, IH; de Keizer, B; de Klerk, JM; Kluijfhout, WP; Valk, GD; Vriens, MR, 2015) |
| "Choline and betaine are involved in methyl-group metabolism as methyl-group donors; thus, like folate, another methyl-group donor, they may be associated with a reduced risk of colorectal adenomas." | 3.74 | Dietary choline and betaine and the risk of distal colorectal adenoma in women. ( Chan, AT; Cho, E; Colditz, GA; Fuchs, CS; Giovannucci, EL; Willett, WC; Wu, K; Zeisel, SH, 2007) |
| "However, no parathyroid adenoma was depictable." | 1.72 | Synchronous Metastatic Medullary Thyroid Carcinoma and Paraesophageal Parathyroid Adenoma Detected on 18 F-Ethylcholine PET/US Fusion Imaging. ( Freesmeyer, M; Männel, M; Mtuka-Pardon, G; Müller, UA; Seifert, P, 2022) |
| "F-Fluorocholine PET/CT was quickly performed considering this discrepancy and not only confirmed the scintigraphic findings but also revealed a second contralateral focus of increased uptake, both later confirmed by operative consideration (the two other parathyroid glands are considered normal by the surgeon), pathology, and intraoperative parathyroid hormone assessment." | 1.46 | Incremental Value of 18F-Fluorocholine PET/CT in the Localization of Double Parathyroid Adenomas. ( Deguelte, S; Lalire, P; Ly, S; Morland, D; Patey, M, 2017) |
| "Prostate carcinoma is the most common cancer in men." | 1.46 | Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT. ( De Gersem, R; De Maeseneer, D; De Man, K; Van den Broeck, B, 2017) |
| "The finding was suggestive for a parathyroid adenoma on subsequent ultrasound, then finally confirmed by parathyroid scintigraphy and histopathological analysis performed after hemithyroidectomy." | 1.38 | Incidental finding of parathyroid adenoma with 11C-choline PET/CT. ( Busnardo, E; Freschi, M; Gianolli, L; Magnani, P; Mapelli, P; Messa, C; Picchio, M, 2012) |
| "Seventy patients with intracranial neoplasms were studied before receiving surgery, radiotherapy or chemotherapy." | 1.29 | Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. ( Calabrese, G; Falini, A; Lipari, S; Losa, M; Origgi, D; Scotti, G; Triulzi, F, 1996) |
Research
Studies (35)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.43) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 5 (14.29) | 29.6817 |
| 2010's | 18 (51.43) | 24.3611 |
| 2020's | 4 (11.43) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Freesmeyer, M | 1 |
| Müller, UA | 1 |
| Männel, M | 1 |
| Mtuka-Pardon, G | 1 |
| Seifert, P | 1 |
| Lenschow, C | 1 |
| Wennmann, A | 1 |
| Hendricks, A | 1 |
| Germer, CT | 1 |
| Fassnacht, M | 1 |
| Buck, A | 1 |
| Werner, RA | 1 |
| Plassmeier, L | 1 |
| Schlegel, N | 1 |
| Aphale, R | 1 |
| Damle, N | 1 |
| Chumber, S | 1 |
| Khan, M | 1 |
| Khadgawat, R | 1 |
| Dharmashaktu, Y | 1 |
| Agarwal, S | 1 |
| Bal, C | 1 |
| Bioletto, F | 1 |
| Barale, M | 1 |
| Parasiliti-Caprino, M | 1 |
| Prencipe, N | 1 |
| Berton, AM | 1 |
| Procopio, M | 1 |
| Deandreis, D | 2 |
| Ghigo, E | 1 |
| Thanseer, N | 1 |
| Bhadada, SK | 1 |
| Sood, A | 1 |
| Mittal, BR | 1 |
| Behera, A | 1 |
| Gorla, AKR | 1 |
| Kalathoorakathu, RR | 1 |
| Singh, P | 1 |
| Dahiya, D | 1 |
| Saikia, UN | 1 |
| Rao, SD | 1 |
| Sindoni, A | 1 |
| Bodanza, V | 1 |
| Tatta, R | 1 |
| Baresic, T | 1 |
| Borsatti, E | 1 |
| Quak, E | 2 |
| Blanchard, D | 1 |
| Houdu, B | 1 |
| Le Roux, Y | 1 |
| Ciappuccini, R | 1 |
| Lireux, B | 1 |
| de Raucourt, D | 1 |
| Grellard, JM | 1 |
| Licaj, I | 1 |
| Bardet, S | 2 |
| Reznik, Y | 2 |
| Clarisse, B | 1 |
| Aide, N | 2 |
| Huber, GF | 1 |
| Hüllner, M | 1 |
| Schmid, C | 1 |
| Brunner, A | 1 |
| Sah, B | 1 |
| Vetter, D | 1 |
| Kaufmann, PA | 1 |
| von Schulthess, GK | 1 |
| Boccalatte, LA | 1 |
| Abuawad, CY | 1 |
| Smith, DE | 1 |
| Figari, MF | 1 |
| Khafif, A | 1 |
| Masalha, M | 1 |
| Landsberg, R | 1 |
| Domachevsky, L | 1 |
| Bernstine, H | 1 |
| Groshar, D | 1 |
| Azoulay, O | 1 |
| Lockman, Y | 1 |
| Lheureux, S | 1 |
| Balogova, S | 1 |
| Michaud, L | 1 |
| Vereb, M | 1 |
| Decazes, P | 1 |
| Huchet, V | 1 |
| Kerrou, K | 1 |
| Fartoux, L | 1 |
| Montravers, F | 1 |
| Rosmorduc, O | 1 |
| Talbot, JN | 1 |
| Orevi, M | 1 |
| Freedman, N | 1 |
| Mishani, E | 1 |
| Bocher, M | 1 |
| Jacobson, O | 1 |
| Krausz, Y | 1 |
| Aziz, AL | 1 |
| Courbon, F | 1 |
| Dierickx, LO | 1 |
| Pascal, P | 1 |
| Zerdoud, S | 1 |
| Kluijfhout, WP | 1 |
| Vriens, MR | 1 |
| Borel Rinkes, IH | 1 |
| Valk, GD | 1 |
| de Klerk, JM | 1 |
| de Keizer, B | 1 |
| Terroir, M | 1 |
| Al Ghuzlan, A | 1 |
| Berdelou, A | 1 |
| Lacroix, L | 1 |
| Bidault, F | 1 |
| Troalen, F | 1 |
| Hartl, D | 1 |
| Lumbroso, J | 1 |
| Baudin, E | 1 |
| Schlumberger, M | 1 |
| Leboulleux, S | 1 |
| Maffione, AM | 1 |
| Mandoliti, G | 1 |
| Pasini, F | 1 |
| Colletti, PM | 2 |
| Rubello, D | 2 |
| Hanley, MP | 1 |
| Kadaveru, K | 1 |
| Perret, C | 1 |
| Giardina, C | 1 |
| Rosenberg, DW | 1 |
| Vellani, C | 1 |
| Hodolič, M | 1 |
| Chytiris, S | 1 |
| Trifirò, G | 1 |
| Lalire, P | 1 |
| Ly, S | 1 |
| Deguelte, S | 1 |
| Patey, M | 1 |
| Morland, D | 1 |
| Van den Broeck, B | 1 |
| De Maeseneer, D | 1 |
| De Gersem, R | 1 |
| De Man, K | 1 |
| JAFFE, WG | 1 |
| Southam, AD | 1 |
| Easton, JM | 1 |
| Stentiford, GD | 1 |
| Ludwig, C | 1 |
| Arvanitis, TN | 1 |
| Viant, MR | 1 |
| Mapelli, P | 1 |
| Busnardo, E | 1 |
| Magnani, P | 1 |
| Freschi, M | 1 |
| Picchio, M | 1 |
| Gianolli, L | 1 |
| Messa, C | 1 |
| Gupta, N | 1 |
| Kakar, AK | 1 |
| Chowdhury, V | 1 |
| Gulati, P | 1 |
| Shankar, LR | 1 |
| Vindal, A | 1 |
| Cho, E | 1 |
| Willett, WC | 1 |
| Colditz, GA | 1 |
| Fuchs, CS | 1 |
| Wu, K | 1 |
| Chan, AT | 1 |
| Zeisel, SH | 1 |
| Giovannucci, EL | 1 |
| Mackinnon, WB | 1 |
| Huschtscha, L | 1 |
| Dent, K | 1 |
| Hancock, R | 1 |
| Paraskeva, C | 1 |
| Mountford, CE | 1 |
| Falini, A | 1 |
| Calabrese, G | 1 |
| Origgi, D | 1 |
| Lipari, S | 1 |
| Triulzi, F | 1 |
| Losa, M | 1 |
| Scotti, G | 1 |
| Hara, T | 1 |
| Kosaka, N | 1 |
| Shinoura, N | 1 |
| Kondo, T | 1 |
| Kinoshita, Y | 1 |
| Yokota, A | 1 |
| Shimizu, C | 1 |
| Yamane, Y | 1 |
| Ishizuka, T | 1 |
| Kijima, H | 1 |
| Takano, K | 1 |
| Takano, A | 1 |
| Kubo, M | 1 |
| Koike, T | 1 |
| Newmark, HL | 1 |
| Yang, K | 1 |
| Lipkin, M | 1 |
| Kopelovich, L | 1 |
| Liu, Y | 1 |
| Fan, K | 1 |
| Shinozaki, H | 1 |
| French, FA | 1 |
| Frasca, JM | 1 |
| Khaletskaia, FM | 1 |
Clinical Trials (3)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas[NCT02432599] | Phase 2 | 28 participants (Actual) | Interventional | 2015-03-31 | Completed | ||
| Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma[NCT01377220] | Phase 2 | 30 participants (Anticipated) | Interventional | 2011-06-30 | Not yet recruiting | ||
| Clinical Value of [18]Fluoroethylcholine Positron-Emission-Tomography Combined With Endorectal Magnetic Resonance Imaging by Software Fusion for Pre-therapeutic Staging of Prostate Cancer[NCT00520546] | Phase 3 | 44 participants (Actual) | Interventional | 2007-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Trial Outcomes
Lesion Based Analysis of FEC-PET, Endorectal MRI and Combined FEC-PET/eMRI in All Patients
PET positive lesions (n=128) were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 59 | 26 | 19 | 24 | 78 | 50 |
| Magnetic Resonance Imaging (MRI) | 40 | 27 | 18 | 43 | 58 | 70 |
| PET/MRI | 55 | 8 | 37 | 28 | 92 | 36 |
Lesion Based Analysis of FEC-PET, Endorectal MRI and Combined FEC-PET/eMRI in Patients With Gleason Score >6 (3+3)
PET positive lesions in patients with Gleason >6(3+3),n=43 were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative & positive predictive values were determined. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 27 | 5 | 8 | 3 | 35 | 8 |
| Magnetic Resonance Imaging (MRI) | 22 | 9 | 4 | 8 | 26 | 17 |
| PET/MRI | 27 | 1 | 11 | 4 | 38 | 5 |
Lesion Based Analysis of FEC-PET, Endorectal MRI and Combined FEC-PET/eMRI in Patients With Malignant Lesions >5mm (n=98)
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. Sensitivity, specificity, accuracy, negative and positive predictive values were determined without malign lesions <=5mm. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | lesions (Number) | |||||
|---|---|---|---|---|---|---|
| True positive | False positive | True negative | False negative | Total true | Total false | |
| FEC-PET | 48 | 24 | 18 | 8 | 66 | 32 |
| Magnetic Resonance Imaging (MRI) | 37 | 26 | 16 | 19 | 53 | 45 |
| PET/MRI | 48 | 8 | 32 | 10 | 80 | 18 |
Number of Participants With Positive or Negative Results in PET, MRI or PET/MRI for Prostate Cancer Compared to Histological Findings
PET positive lesions were measured on its own and evaluated as malignant just as hypointense lesions on MRI. In PET/MRI analysis, MRI suspect lesions without FEC uptake were considered not to be malignant. PET positive lesions in central periurethral zone with inhomogenous signal intensity and sharp edges on MRI images were also considered to be benign. PET positive lesions in the peripheral zone without a hypointense correlate on MRI were considered to be malignant. At least 1 histological confirmed cancer lesion has to be detected by each of the 3 methods to be patient based true positive. (NCT00520546)
Timeframe: within < 2 weeks after PET/MRI
| Intervention | participants (Number) | |||||
|---|---|---|---|---|---|---|
| True Positive | False Positive | True Negative | False Negative | Total True | Total False | |
| [18F]Fluoroethylcholine Positron-Emission-Tomography (FEC-PET) | 36 | 1 | 0 | 1 | 36 | 2 |
| Magnetic Resonance Imaging (MRI) | 26 | 1 | 0 | 11 | 27 | 11 |
| PositronEmissionTomography/MagneticResonanceImaging (PET/MRI) | 35 | 0 | 1 | 2 | 36 | 2 |
Reviews
1 review available for choline and Adenoma
| Article | Year |
|---|---|
Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis.
Topics: Adenoma; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Hyperparathyroidism, Primary | 2021 |
Trials
2 trials available for choline and Adenoma
| Article | Year |
|---|---|
Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
Topics: Adenoma; Adult; Aged; Choline; Female; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Para | 2017 |
Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results.
Topics: Adenoma; Adult; Aged; Calcium; Carbon Radioisotopes; Choline; Female; Humans; Hyperthyroidism; Male; | 2014 |
Other Studies
32 other studies available for choline and Adenoma
| Article | Year |
|---|---|
Synchronous Metastatic Medullary Thyroid Carcinoma and Paraesophageal Parathyroid Adenoma Detected on 18 F-Ethylcholine PET/US Fusion Imaging.
Topics: Adenoma; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Choline; Female; Humans; Parathyr | 2022 |
Questionable value of [
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Choline; Female; Humans; Hyperparathyroidism, P | 2022 |
Impact of Fluoro-Choline PET/CT in Reduction in Failed Parathyroid Localization in Primary Hyperparathyroidism.
Topics: Adenoma; Choline; Humans; Hyperparathyroidism, Primary; Parathyroid Glands; Parathyroid Neoplasms; P | 2023 |
Ectopic Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Localized by 18F-Choline PET/CT.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Choline; Humans; Male; Middle Aged; Positron Emission Tom | 2018 |
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.
Topics: Adenoma; Aged; Choline; Female; Fluorine Radioisotopes; Humans; Hyperparathyroidism, Primary; Male; | 2018 |
Benefit of
Topics: Adenoma; Aged; Aged, 80 and over; Choline; Female; Fluorine Radioisotopes; Humans; Hyperparathyroidi | 2018 |
[Mediastinal parathyroid adenoma detected by PET/CT with 18F choline].
Topics: Adenoma; Adolescent; Choline; Fluorine Radioisotopes; Humans; Male; Parathyroid Neoplasms; Positron | 2018 |
The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas.
Topics: Adenoma; Adult; Aged; Choline; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; | 2019 |
F18-choline, a novel PET tracer for parathyroid adenoma?
Topics: Adenoma; Aged; Choline; Fluorine Radioisotopes; Humans; Male; Multimodal Imaging; Parathyroid Neopla | 2013 |
18F-fluorocholine may be taken-up by brown adipose tissue.
Topics: Adenoma; Adipose Tissue, Brown; Adult; Artifacts; Choline; Diagnosis, Differential; False Positive R | 2013 |
Oncocytic Adenoma of Thyroid Incidentally Detected by 18F-Fluorocholine PET/CT.
Topics: Adenoma; Choline; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emiss | 2015 |
[18F-Fluorocholine PET-CT for localization of parathyroid adenomas].
Topics: Adenoma; Choline; Contrast Media; Humans; Hyperparathyroidism, Primary; Parathyroid Neoplasms; Posit | 2015 |
¹⁸Fluorocholine PET/CT in parathyroid carcinoma: a new tool for disease staging?
Topics: Adenoma; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Parathyroid Neopl | 2015 |
Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse.
Topics: Adenoma; Choline; Humans; Incidental Findings; Male; Middle Aged; Pituitary Neoplasms; Positron Emis | 2016 |
Dietary Methyl Donor Depletion Suppresses Intestinal Adenoma Development.
Topics: Adenoma; Animals; Choline; Diet; Folic Acid; Intestinal Neoplasms; Methionine; Mice; Mice, Inbred C5 | 2016 |
Early and Delayed 18F-FCH PET/CT Imaging in Parathyroid Adenomas.
Topics: Adenoma; Adult; Choline; Humans; Male; Parathyroid Neoplasms; Positron Emission Tomography Computed | 2017 |
Incremental Value of 18F-Fluorocholine PET/CT in the Localization of Double Parathyroid Adenomas.
Topics: Adenoma; Aged; Choline; Humans; Male; Parathyroid Neoplasms; Positron Emission Tomography Computed T | 2017 |
Parathyroid Adenoma Mimicking a Malignant Lymph Node on 18F-Choline PET-CT.
Topics: Adenoma; Carcinoma; Choline; Diagnosis, Differential; Humans; Lymphatic Metastasis; Male; Middle Age | 2017 |
The influence of sodium thiosulfate on experimental tumor induction.
Topics: Adenoma; Animals; Choline; Choline Deficiency; Humans; Liver; Liver Neoplasms; Neoplasms; Neoplasms, | 1948 |
Metabolic changes in flatfish hepatic tumours revealed by NMR-based metabolomics and metabolic correlation networks.
Topics: Adenoma; Animals; Choline; Computational Biology; Environment; False Positive Reactions; Flatfishes; | 2008 |
Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
Topics: Adenoma; Aged; Carbon Radioisotopes; Choline; Humans; Incidental Findings; Male; Multimodal Imaging; | 2012 |
Magnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroid.
Topics: Adenocarcinoma, Follicular; Adenocarcinoma, Mucinous; Adenoma; Adolescent; Adult; Biopsy, Fine-Needl | 2007 |
Dietary choline and betaine and the risk of distal colorectal adenoma in women.
Topics: Adenoma; Adult; Betaine; Choline; Colorectal Neoplasms; Diet; Female; Humans; Middle Aged; Risk; Uni | 2007 |
Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy.
Topics: Adenoma; Amino Acids; Carbohydrates; Cell Differentiation; Choline; Colorectal Neoplasms; Diagnosis, | 1994 |
Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.
Topics: Adenoma; Aspartic Acid; Brain Neoplasms; Choline; Craniopharyngioma; Creatinine; Glioma; Humans; Lym | 1996 |
PET imaging of brain tumor with [methyl-11C]choline.
Topics: Adenoma; Aged; Animals; Brain; Brain Neoplasms; Carbon Radioisotopes; Choline; Chromatography, High | 1997 |
PET imaging of brain tumor with [methyl-11C]choline.
Topics: Adenoma; Aged; Animals; Brain; Brain Neoplasms; Carbon Radioisotopes; Choline; Chromatography, High | 1997 |
PET imaging of brain tumor with [methyl-11C]choline.
Topics: Adenoma; Aged; Animals; Brain; Brain Neoplasms; Carbon Radioisotopes; Choline; Chromatography, High | 1997 |
PET imaging of brain tumor with [methyl-11C]choline.
Topics: Adenoma; Aged; Animals; Brain; Brain Neoplasms; Carbon Radioisotopes; Choline; Chromatography, High | 1997 |
Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Topics: Adenoma; Adolescent; Adult; Aged; Amino Acids; Brain; Brain Neoplasms; Child; Choline; Creatine; Fem | 1997 |
Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenocorticotropic Hormone; Atropine; Choline; | 2001 |
A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice.
Topics: Adenoma; Animals; Body Weight; Bromodeoxyuridine; Cell Division; Choline; Colonic Neoplasms; Diet; D | 2001 |
The influence of nutritional factors on pulmonary adenomas in mice.
Topics: Adenoma; Animals; Body Weight; Choline; Inositol; Lung Neoplasms; Mice; Mice, Inbred Strains; Niacin | 1977 |
In vivo incorporation of 3H-choline in murine pulmonary adenoma cells: an electron microscopic radioautographic study;.
Topics: Adenoma; Animals; Choline; Endoplasmic Reticulum; Golgi Apparatus; Inclusion Bodies; Lung Neoplasms; | 1977 |
[On the pathomorphology of tumors induced by benzocholine 69].
Topics: Adenocarcinoma; Adenoma; Animals; Benzene; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Choline; | 1969 |